MXCT R&D to Revenue
Maxcyte Inc · R&D to Revenue
MXCT R&D to Revenue
Latest reported58.49%period ending
MXCT Quarterly R&D/Revenue (41.18% → 58.49%)
Latest values, visible window
High-resolution chart · PNG
MXCT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 58.4926% | |
| 39.9648% | |
| 45.6849% | |
| 77.8445% | |
| 73.6923% | |
| 56.8142% | |
| 53.0772% | |
| 65.1151% | |
| 53.8786% | |
| 58.8785% | |
| 37.2949% | |
| 78.2609% | |
| 62.6341% | |
| 70.5107% | |
| 46.1058% | |
| 50.0348% | |
| 48.877% | |
| 32.4951% | |
| 33.3038% | |
| 27.0921% | |
| 45.0739% | |
| 93.5549% | |
| 57.4524% | |
| 66.8071% | |
| 79.4191% | |
| 73.9237% | |
| 59.5468% | |
| 59.6811% | |
| 115.7847% | |
| 115.7847% | |
| 65.0231% | |
| 65.0231% | |
| 70.8903% | |
| 70.8903% | |
| 91.2192% | |
| 91.2192% | |
| 67.5126% | |
| 67.5126% | |
| 38.8619% | |
| 38.8619% | |
| 37.5494% | |
| 37.5494% | |
| 30.794% | |
| 30.794% | |
| 34.3023% | |
| 34.3023% | |
| 30.2385% | |
| 30.2385% | |
| 41.1793% | |
| 41.1793% |